NFYA-transcriptionally activated MTHFD2 promotes cervical cancer progression by inducing mitochondrial dysfunction via AMT

Yanli He, Tingting Xie, Fuxing Zhou, Yun Gong, Ying Tai, Wei Zhang

Open source

DOI
10.1016/j.molimm.2026.10.011
Published
2026-12
Container
Molecular Immunology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.molimm.2026.10.011,
  title = {NFYA-transcriptionally activated MTHFD2 promotes cervical cancer progression by inducing mitochondrial dysfunction via AMT},
  author = {Yanli He and Tingting Xie and Fuxing Zhou and Yun Gong and Ying Tai and Wei Zhang},
  year = {2026},
  journal = {Molecular Immunology},
  doi = {10.1016/j.molimm.2026.10.011},
  url = {https://doi.org/10.1016/j.molimm.2026.10.011}
}

RIS

TY  - JOUR
TI  - NFYA-transcriptionally activated MTHFD2 promotes cervical cancer progression by inducing mitochondrial dysfunction via AMT
AU  - Yanli He
AU  - Tingting Xie
AU  - Fuxing Zhou
AU  - Yun Gong
AU  - Ying Tai
AU  - Wei Zhang
PY  - 2026
JO  - Molecular Immunology
DO  - 10.1016/j.molimm.2026.10.011
UR  - https://doi.org/10.1016/j.molimm.2026.10.011
ER  - 

APA

He, Y., Xie, T., Zhou, F., Gong, Y., Tai, Y., & Zhang, W. (2026). NFYA-transcriptionally activated MTHFD2 promotes cervical cancer progression by inducing mitochondrial dysfunction via AMT. Molecular Immunology. https://doi.org/10.1016/j.molimm.2026.10.011

Source records